Amanda Pigott, Hiroo Suami, Andrew McCann and Megan Trevethan

Abstract

      Head and neck lymphoedema occurs frequently after head and neck cancer treatment and causes physical and psychosocial disability. Imaging is not routinely used to diagnose or inform its conservative treatment. Indocyanine green (ICG) lymphography is used for these purposes in upper and lower limb lymphoedema.

Aim: The study aimed to explore the clinical potential of ICG lymphography in diagnosis and conservative management of head and neck lymphoedema.

Methods: Participants underwent a single examination with ICG lymphography. The tracer injection sites were determined by anatomic lymphatic territories. Presence of dermal backflow was used to diagnose lymphoedema. Imaging data were recorded using a bespoke audit tool to document lymphatic movement features and manual lymphatic drainage observations.

Results: Six participants underwent head and neck ICG lymphography. Lymphatic vessels and dermal backflow were visualised in all participants. Manual lymphatic drainage observations suggested all participants required very firm pressure to move the ICG dye through areas of dermal backflow, whereas only light pressure was required in areas with linear lymphatic vessel flow.

Conclusion: ICG lymphography can identify lymphatic structures and drainage patterns in the head and neck region and is considered a potential tool for diagnosis and conservative treatment planning for head and neck lymphoedema.

Key words：Head and neck cancer, lymphoedema, indocyanine green, fluorescence imaging

      Amanda Pigott is Clinical Specialist, Department of Occupational Therapy, Princess Alexandra Hospital, Brisbane; and Honorary Research Fellow, University of Queensland, Brisbane, Australia. Hiroo Suami is Associate Professor, Australian Lymphoedema Education, Research and Treatment (ALERT) Program, Department of Human Sciences, Macquarie University, Sydney, Australia. Andrew McCann is Director, Department of Vascular Medicine, Princess Alexandra Hospital, Brisbane, Australia. Megan Trevethan is Clinical Specialist, Department of Occupational Therapy, Princess Alexandra Hospital, Brisbane; and PhD candidate, University of Queensland, Brisbane, Australia. Declaration of interest: None.

      Acknowledgments: The authors acknowledge the participants who donated their time for this research.

      Data availability: Contact corresponding author (该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。) to discuss.

      Funding : This work was supported by a grant from the PA Research Foundation 2019 Research Awards.

      The article highlights the major challenge of limb amputation in the Caribbean and its effects on the patient’s quality of life, stressors on the family and the burden on the healthcare system. Four clinical cases are presented with various wound aetiologies and comorbidities; these patients were candidates for limb amputation. A reassessment of the traditional wound management approach paradigmatically shifted to a new strategy. This strategy includes clinically effective, easy-to-apply, and affordable products that help to reduce limb amputation, resulting in limb salvage.

Authors:

Larry G. Baratta and Yvonne Braithwaite Superville

Larry G. Baratta is International Medical Director, Chief Medical Officer - World Wide Wound Care, LLC;

Yvonne Braithwaite is Chief Executive Officer - Rovon Foot and Wound Care Clinic

      The article highlights the major challenge of limb amputation in the Caribbean and its effects on the patient’s quality of life, stressors on the family and the burden on the healthcare system. Four clinical cases are presented with various wound aetiologies and comorbidities; these patients were candidates for limb amputation. A reassessment of the traditional wound management approach paradigmatically shifted to a new strategy. This strategy includes clinically effective, easy-to-apply, and affordable products that help to reduce limb amputation, resulting in limb salvage.

Authors:

Larry G. Baratta and Yvonne Braithwaite Superville

Larry G. Baratta is International Medical Director, Chief Medical Officer - World Wide Wound Care, LLC;

Yvonne Braithwaite is Chief Executive Officer - Rovon Foot and Wound Care Clinic

MANAGING THE CHALLENGES AND RISKS OF INFECTION IN WOUND CARE

USE OF DIFFERENT ANTISEPTICS IN PRACTICE

WOUND CLEANSING AND TIPS FOR BEST PRACTICE

GUIDANCE AND PATHWAYS FOR ANTISEPTIC USE

THE IMPORTANCE OF AN ANTIMICROBIAL STEWARDSHIP-FOCUSED APPROACH

EXPERT PANEL

Harikrishna K. R. Nair (Chair), Professor and Head of the Wound Care Unit, Department of Internal Medicine, Kuala Lumpur Hospital, Malaysia

Beata Mrozikiewicz-Rakowska, President of the Polish Wound Management Association, Department of Endocrinology, Medical Centre of Postgraduate Education, Warsaw, Poland

Debora Sanches Pinto, Assistant Physician, Division of Plastic Surgery and Burns, University of São Paulo Faculty of Medicine Clinics Hospital, São Paulo, Brazil

Ewa K. Stuermer, Professor, Surgical Head of the Comprehensive Wound Center, Head of Translational Research, Department for Vascular Medicine, University Hospital Hamburg-Eppendorf, Hamburg, Germany

Johannes Matiasek, Associate Professor and Specialist in Plastic, Reconstructive and Aesthetic Surgery, Medizin am Kärntner Ring, Vienna, Austria

Johanna Sander, Head of Advanced Wound Care, 2 Military Hospital, Cape Town, South Africa

José Luis Lázaro-Martínez, Professor, The Complutense University of Madrid; Clinical Director, Complutense University Podiatric Clinic; Head of Diabetic Foot Unit, University Podiatric Clinic, Madrid, Spain

Karen Ousey, Professor of Skin Integrity, Director for the Institute of Skin Integrity and Infection Prevention, University of Huddersfield, United Kingdom

Ojan Assadian, Medical Director, Hospital Wiener Neustadt, Austria; Professor Emeritus, University of Huddersfield, United Kingdom

Paul J. Kim, Medical Director, University of Texas Southwestern Medical Center; Professor, Department of Plastic Surgery and Orthopaedic Surgery, University of Texas Southwestern, United States

Steven L. Percival, Professor (Honorary), University of Manchester, United Kingdom; CEO and Director, Biofilm Centre, 5D Health Protection Group Ltd, Liverpool, United Kingdom

PUBLISHED BY: Wounds International 108 Cannon Street London EC4N 6EU, UK

Tel: + 44 (0)20 7627 1510 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。 www.woundsinternational.com

© Wounds International, 2023

The meeting and this document have been supported by B Braun, Bactiguard, Schülke and Urgo Medical.

The views in this document do not necessarily reflect those of the sponsors.

How to cite this document: Nair HKR et al (2023) International Consensus Document: Use of wound antiseptics in practice. Wounds International. Available online at www.woundsinternational. com